FGFR3 Testing Frequency and Outcomes in Patients Treated with Enfortumab-Vedotin for Metastatic Urothelial Carcinoma and FGFR3-Alteration: An Austrian Multicentre Study
- C Krallinger (Author)
- H Saadi (Author)
- K Mayrhofer (Author)
- J Krauter (Author)
- D Kiesl (Author)
- D Vais (Author)
- S Schnabel (Author)
- SP Gampenrieder (Author)
- J Miechowiecki (Author)
- CG Wiesinger (Author)
- A Banner (Author)
- F Stoiber (Author)
- Jasmin Alija Spiegelberg (Author)
- J Mühlmann (Author)
- S Vallet (Author)
- H Andalibi (Author)
- S Aufderklamm (Author)
- S Weibrecht (Author)
- W Hilbe (Author)
- S Shariat (Author)
- J Pfuner (Author)
- D Heintel (Author)
- R Pichler (Author)
- D Niedersüss-Beke (Author)
Activity: Talk, presentation or poster › Poster